All Stories

  1. MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
  2. MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
  3. Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact. Cancers 2024, 16, 4210
  4. Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact
  5. Female performance in skyrunning: biological and psychosocial aspects
  6. Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial
  7. Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus
  8. The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis
  9. Safety and efficacy of non-ablative CO2 laser treatment of vulvo-vaginal atrophy in women with history of breast cancer
  10. Association Between Albumin Alterations and Renal Function in Patients With Type 2 Diabetes Mellitus
  11. Development and internal validation of a multivariable model for the prediction of the probability of 1-year readmission to the emergency department for acute alcohol intoxication
  12. Albumin administration in internal medicine: A journey between effectiveness and futility
  13. Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study
  14. Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation
  15. Predictors of clinical trajectories in patients admitted for acutely decompensated cirrhosis: An external validation of the PREDICT study
  16. Effect of ospemifene on vaginal microbiome in postmenopausal women with vulvovaginal atrophy
  17. Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study
  18. Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study Database
  19. A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study
  20. Predictive factors of inhospital mortality for ICU patients with acute-on-chronic liver failure undergoing liver transplantation
  21. Low hemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation
  22. Vaginal metabolites in postmenopausal women with or without vulvo-vaginal atrophy at baseline and after ospemifeme and systemic hormone treatment
  23. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy
  24. Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
  25. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
  26. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites
  27. Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study
  28. Knowledge of genito-urinary syndrome of menopause among Italian gynecologists: the DIADEM survey
  29. Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study
  30. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
  31. Author Correction: Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors: First Italian Clinical Trial
  32. Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701]
  33. Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial
  34. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
  35. Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial
  36. Effective albumin concentration and albumin function improve after long-term albumin therapy in patients with decompensated cirrhosis
  37. Long-term albumin therapy is not futile in patients with cirrhosis and uncomplicated ascites not normalizing on-treatment serum albumin concentration
  38. Subtle changes of c-reactive protein and serum creatinine during the index hospitalization predict early readmission in patients with decompensated cirrhosis
  39. The Analysis of Food Intake in Patients with Cirrhosis Waiting for Liver Transplantation: A Neglected Step in the Nutritional Assessment
  40. Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
  41. Vaginal Health in Menopausal Women
  42. Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial (Preprint)
  43. PS-102-Circulating native albumin in patients with cirrhosis admitted to hospital for acute decompensation and acute-on-chronic liver failure: Relation to serum albumin levels, albumin function, and patient outcomes
  44. SAT-152-Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
  45. A Mediterranean Diet Mix Has Chemopreventive Effects in a Murine Model of Colorectal Cancer Modulating Apoptosis and the Gut Microbiota
  46. MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
  47. Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses
  48. Long-term albumin administration in patients with cirrhosis and uncomplicated ascites: the use of serum albumin concentration for personalizing treatment
  49. Predictors of nosocomial acute-on-chronic liver failure for the risk stratification of patients with cirrhosis admitted to hospital with acute decompensation
  50. The residual native albumin predicts albumin dysfunction and outcomes in hospitalized cirrhotic patients with acute decompensation or acute-on-chronic liver failure
  51. Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study
  52. New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy
  53. Structure of Epithelial and Stromal Compartments of Vulvar and Vaginal Tissue From Women With Vulvo-Vaginal Atrophy Taking Ospemifene
  54. Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration
  55. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
  56. The use of human albumin in patients with cirrhosis: a European survey
  57. Outcome of bacterial infections complicated or not by acute-on-chronic liver failure in patients with cirrhosis admitted to hospital for acute decompensation
  58. Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study
  59. Bacterial infections with and without acute-on-chronic liver failure in patients with cirrhosis and acute decompensation: Risk factors and outcome
  60. Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts
  61. The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
  62. Molecular and functional characterization of CD133 + stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells
  63. Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis
  64. Simple and rapid LC–MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress
  65. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections
  66. In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
  67. Effects of ospemifene on vaginal epithelium of post-menopausal women
  68. Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule
  69. Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis
  70. The TLR10 polymorphism rs4129009 is associated to poor 28-day survival in patients with cirrhosis and acute on chronic liver failure precipitated by bacterial infection
  71. Inadequate Nutrition in Patients with Cirrhosis: The Need of a Personalized Educational Program
  72. Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women
  73. TLR-10 Single Nucleotide Polymorphism is Associated to Poor Short Term Survival in Cirrhotic Patients with Acute on Chronic Liver Failure Precipitated by Bacterial Infections
  74. Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases
  75. Response to The reduced CO2+ -binding ability of ischaemia-modified albumin is unlikely to be because of oxidative modification of the N-terminus”
  76. Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes
  77. Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis
  78. Reply to the Letter to the Editor: How Does Sleep Relate to Metabolic Syndrome in Women with Sexual Dysfunction?
  79. Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosis
  80. Clinical and prognostic relevance of albumin dimers in patients with cirrhosis: A novel identified structural alteration of the molecule
  81. Sexuality and Psychopathological Aspects in Premenopausal Women with Metabolic Syndrome
  82. Endocannabinoids and liver cirrhosis: The endocannabinoid-related molecule oleoyl-ethanolamine (OEA) correlates with clinical complications and 1-year survival
  83. Ischemia modified albumin (IMA) for the diagnosis of bacterial infection in hospitalized patients with cirrhosis
  84. The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives
  85. Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women
  86. 580 POST-TRANSCRIPTIONAL CHANGES OF SERUM ALBUMIN ARE ASSOCIATED WITH CLINICAL FEATURES AND POOR SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS
  87. OC-35 Post-transcriptional changes of serum albumin and its relationship with clinical features and prognosis in cirrhotic patients
  88. A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field
  89. O1 ADMINISTRATION OF THE CANNABINOID CB1-RECEPTOR ANTAGONIST PROTECTS AGAINST SEPSIS IN RAT CIRRHOSIS
  90. Androgen receptor expression in the human vagina under different physiological and treatment conditions
  91. 569 ENDOCANNABINOIDS AND CIRRHOSIS: HAVE WE PICKED THE RIGHT ONE?
  92. F-27 Endocannabinoids in advanced cirrhosis: have we picked the right one?
  93. Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis
  94. Hyperoxia fully protects mitochondria of explanted livers
  95. F.N.10 PHARMACOLOGICAL ANTAGONISM OF ENDOCANNABINOID CB1 RECEPTOR AMELIORATES LIVER FIBROSIS IN A RAT MODEL OF ADVANCED CIRRHOSIS
  96. A novel model of CCl4-induced cirrhosis with ascites in the mouse
  97. 748 EFFECT OF B3-ADRENOCEPTOR MODULATION ON PORTAL PRESSURE IN RATS WITH COMPENSATED CIRRHOSIS
  98. Effect of β3-adrenoceptor agonist SR58611A on portal pressure of rats with compensated cirrhosis
  99. A novel experimental model of decompensated liver cirrhosis induced by CCl4 inhalation in mice
  100. SPASE-I: a multicenter observational study on pharmacological treatment of acute stroke in the elderly
  101. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system